Aim ImmunotechAIM
13F holders, Q2 2025 (June 30)12holders
$8.65avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Aim Immunotech Inc. (AIM) in their 13F filings. The largest holders were Corient Private Wealth LP ($87K), UBS Group AG ($10K) and Morgan Stanley ($7K).
- Company
- Aim Immunotech Inc.
- CUSIP
- 00901B303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $105K |
| Exits | 0 | $0 |
Ownership 12 holders
| Corient Private Wealth LP | 0.00% | New | 10,001 | $87K |
| UBS Group AG | 0.00% | New | 1,181 | $10K |
| Morgan Stanley | 0.00% | New | 762 | $7K |
| Community Bank, N.A. | 0.00% | New | 132 | $1K |
| Harbour Investments, Inc. | 0.00% | New | 10 | $87 |
| Hoey Investments, Inc. | 0.00% | New | 10 | $87 |
| Osaic Holdings, Inc. | 0.00% | New | 10 | $86 |
| Bank of America Corp. | 0.00% | New | 5 | $43 |
| Wells Fargo & Company | 0.00% | New | 4 | $35 |
| Danske Bank A/S | 0.00% | New | 3 | $26 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 2 | $17 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $9 |
"% of holder's portfolio" is AIM's weight in each manager's 13F, not the share of Aim Immunotech Inc. the manager owns.